ClinConnect ClinConnect Logo
Search / Trial NCT00809081

Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy

Launched by YONSEI UNIVERSITY · Dec 15, 2008

Trial Information

Current as of April 25, 2025

Unknown status

Keywords

Periampullar Carcinoma Pancreaticoduodenectomy Enteral Feeding Total Parenteral Support

ClinConnect Summary

Pancreaticoduodenectomy is associated with a high incidence of postoperative complications. These postoperative complications could delay postoperative resumption of adequate oral intake. The use of TPN significantly increases postoperative complications, especially those associate with infections. However, method of Nutritional support (Enteral feeding or total parenteral support)after pancreaticoduodenectomy is controversial.

1. To evaluate whether early enteral nutrition may be decreased the postoperative complications
2. To evaluate whether enteral feeding improve nutritional status af...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Periampullar carcinoma
  • Pancreaticoduonectomy
  • KARNOFSKY PERFORMANCE SCALE \> 70
  • No history of Major operation
  • Exclusion Criteria:
  • Creatinine level\>3mg/L
  • Ascitis/portal hypertension
  • New York Heart Association class\>3
  • COPD
  • Preoperative Radiotheraly/chemotherapy
  • Unresectable primary cancer
  • Palliative surgery

About Yonsei University

Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.

Locations

Seoul, , Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Dong Sup Yoon, MD,PhD

Principal Investigator

Yonsei University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials